Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-137,130
Closed -$13.4M 4221
2018
Q1
$13M Buy
+137,130
New +$15.1M 0.06% 354
2016
Q4
Sell
-65,173
Closed -$3.98M 4631
2016
Q3
$4.11M Buy
+65,173
New +$4.22M 0.03% 803
2016
Q2
Sell
-530
Closed -$32.3K 4224
2016
Q1
$30K Sell
530
-135,438
-100% -$7.55M ﹤0.01% 4024
2015
Q4
$8.05M Sell
135,968
-249,874
-65% -$14.4M 0.05% 466
2015
Q3
$21M Buy
385,842
+251,026
+186% +$16.3M 0.11% 215
2015
Q2
$9.06M Sell
134,816
-8,090
-6% -$528K 0.05% 491
2015
Q1
$8.37M Buy
142,906
+66,637
+87% +$4.03M 0.06% 405
2014
Q4
$4.99M Buy
76,269
+58,369
+326% +$3.68M 0.04% 686
2014
Q3
$1.03M Hold
17,900
0.01% 1797
2014
Q2
$1.01M Buy
17,900
+14,556
+435% +$764K 0.01% 1628
2014
Q1
$172K Buy
+3,344
New +$169K ﹤0.01% 3543
2013
Q4
Sell
-24,128
Closed -$1.19M 4815
2013
Q3
$541K Buy
24,128
+2,572
+12% +$114K ﹤0.01% 2749
2013
Q2
$892 Buy
+21,556
New +$943K ﹤0.01% 2234

Other funds holding ABBV

PEAK6 Group's ABBV Position: Q2 2018 in Review

PEAK6 Group sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 137,130 shares — an estimated $13.4M sold.

PEAK6 Group first reported a position in ABBV in Q2 2013 and held it in 13 quarters. The position peaked at $21M in Q3 2015. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • PEAK6 Group reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 137,130 AbbVie shares in Q2 2018, an estimated $13.4M.
  • PEAK6 Group first reported a position in AbbVie in Q2 2013 and held it in 13 quarters.
  • PEAK6 Group's AbbVie position peaked at $21M in Q3 2015.
  • 1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.